UW News
Kai Yeung
June 15, 2021
Drug rebates for insurers tied to higher costs for patients, especially the uninsured
Federal agencies that regulate drug pricing and healthcare insurance are concerned that an industry practice of using rebates to lower drug costs for insurers has led to increases in list prices and out-of-pockets costs for patients. To investigate whether patients with or without insurance were paying more because of rebates to insurers, researchers led by…
